Dennis Bourdette

9PUBLICATIONS
4CO-AUTHORS
Gene and molecular therapyMedical mycologyPredictive and prognostic markersPricing (incl. consumer value estimation)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 06, 2026
Industry Payments to Physicians Alter the Care of Patients With Multiple Sclerosis: It's Time to Cut Financial Ties.

Dennis Bourdette, Daniel M Hartung

|Jan 26, 2026
Stop the Spin: Confronting Reporting Bias in Multiple Sclerosis Research.

Dennis Bourdette, Elizabeth Silbermann

|Jul 16, 2025
Late-Onset Multiple Sclerosis: Is Disease-Modifying Therapy Indicated?

Dennis Bourdette, Lindsey Wooliscroft

|Jan 08, 2025
Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare Program.

Daniel M Hartung, Sheila Markwardt, Dennis Bourdette

|Aug 28, 2024
Investigating When Patients With Multiple Sclerosis Should Switch From a Low- or Moderate-Efficacy Therapy to a High-Efficacy Treatment.

Dennis Bourdette

|Feb 23, 2024
The Challenges of Treating Late-Onset Multiple Sclerosis.

Dennis Bourdette, Lindsey Wooliscroft

Pageof 2

Frequent Collaborators

2 joint publications

Elizabeth Silbermann

2 joint publications

Lindsey Wooliscroft

2 joint publications

Daniel M Hartung

1 joint publications

Sheila Markwardt